Search company, investor...

Staten Biotechnology

statenbiotech.com

Founded Year

2014

Stage

Other Investors | Alive

About Staten Biotechnology

Staten Biotechnology develops technology and strategies for the prevention of cardiovascular events. Staten develops a human monoclonal antibody with an approach towards neutralizing apoC3 - a molecule in dyslipidemia managemen - which reduces triglyceride levels and increases the removal of atherogenic lipoprotein remnant particles.

Headquarters Location

Transistorweg 5J

Nijmegen, 6534,

Netherlands

+31 357606500

Missing: Staten Biotechnology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Staten Biotechnology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Staten Biotechnology Patents

Staten Biotechnology has filed 10 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Virus families
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/13/2019

2/15/2022

Molecular biology, Virus families, Biotechnology, Fatty acids, Immune system

Grant

Application Date

12/13/2019

Grant Date

2/15/2022

Title

Related Topics

Molecular biology, Virus families, Biotechnology, Fatty acids, Immune system

Status

Grant

Latest Staten Biotechnology News

Novo-partner indleder forsøg i mennesker med middel mod hjerte-kar-sygdom

Jul 23, 2020

Staten Biotechnology, som Novo Nordisk i 2018 indgik partnerskab med, har indledt kliniske studier med et potentielt middel mod hjerte-kar-sygdom. En købsoption giver danskerne mulighed for senere at overtage det hollandske selskab. Novo Nordsik er trådt et skridt nærmere potentielt opkøb af det hollandske biotekselska Staten Biotechnology Foto: Tidsvilde Stine/Ritzau Scanpix

Staten Biotechnology Frequently Asked Questions (FAQ)

  • When was Staten Biotechnology founded?

    Staten Biotechnology was founded in 2014.

  • Where is Staten Biotechnology's headquarters?

    Staten Biotechnology's headquarters is located at Transistorweg 5J, Nijmegen.

  • What is Staten Biotechnology's latest funding round?

    Staten Biotechnology's latest funding round is Other Investors.

  • Who are the investors of Staten Biotechnology?

    Investors of Staten Biotechnology include Forbion European Acquisition and BioGeneration Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.